It has been proposed that non-canonical insulin signaling might be mediated by the actions of these IGs, offering new alternatives for the treatment of diseases linked to carbohydrate metabolisms such as insulin resistance and Type 2 Diabetes [9]. Here, INS is linked to type 2 diabetes mellitus.